Rehydra+ Wellness
Rehydra+ Wellness is a San Antonio telehealth shop with a long peptide shelf, but its peptide product pages redirect to a login screen, so the catalog listing is the only place a price survives.
Review by Craig Palmer, peptide pharmacology writer · Updated October 2026
The short version
The GLP-1 side of this shop is the transparent half, because each membership tier prints the milligram range it covers and the full price it discounts from. The peptide side is the opposite: open the sermorelin, GHK-Cu or tesamorelin page and the site sends you to an account login instead, leaving a figure on the shop grid and nothing behind it. The GLP-1 tiers are also six months long and non-cancelable.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Lowest listed: Semaglutide injection, from $149 per 4 wks ($161 a calendar month, our arithmetic)
20 states, per the About page; no list of which states is published
Visit Rehydra+ Wellness →Rehydra+ Wellness is a cash-pay telehealth practice that began as a mobile IV service and now sells compounded medicines from a San Antonio address, with a shop built as an ordinary online storefront rather than a program funnel. The weight-loss side is compounded semaglutide and tirzepatide, sold either as a six-month membership tier or as a one-time vial. The peptide side is longer: sermorelin, NAD+, GHK-Cu, BPC-157, a BPC-157 and thymosin beta-4 blend, KPV, and two multi-peptide blends the site calls Glow and Klow. Testosterone therapy and a lipotropic injection sit alongside them. The About page says the practice serves patients in 20 states.
What Rehydra+ Wellness prescribes, by goal
Weight
- SemaglutideFDA-approved
- Injection (compounded)From $149 per 4 wks$161 a calendar month, our arithmetic
- TirzepatideFDA-approved
- Injection (compounded)From $219 per 4 wks$237 a calendar month, our arithmetic
The membership tiers are where this shop prints a dose, and they print it clearly. Semaglutide tier one covers 0.25 mg and 0.5 mg, tier two 0.75 mg and 1.0 mg, and tier three 1.7 mg and 2.5 mg, all once weekly. Tirzepatide runs 2.5 mg and 5 mg, then 7.5 mg and 10 mg, then 12.5 mg and 15 mg. Every tier is valid for six months and marked non-cancelable.
Longevity
- NAD+Legal to compound
- Injection (compounded)From $279 per vial
- Oral (compounded)From $279 per 4 wks$302.25 a calendar month, our calendar-month conversion
- Nasal spray (compounded)From $279 per 4 wks$302.25 a calendar month, our calendar-month conversion
NAD+ is $279 for four weeks, which the page calls a full 30-day supply, and it is one of the few peptide pages here a reader can actually open. The same $279 buys it as an injection, a nasal spray or an oral form, and eight or twelve weeks cost $449 or $619. No milligram is printed, and the page tells you your provider will set the dosing schedule during the consultation.
Recovery
- SermorelinLegal to compound
- Injection (compounded)Price not published
Sermorelin is listed at $250 on the shop grid, and that is as far as a reader gets: the product page redirects to an account login, as do the GHK-Cu, BPC-157 and tesamorelin pages.
Sleep
- SermorelinLegal to compound
- Injection (compounded)Price not published
Nothing on the reachable part of the site says when sermorelin is meant to be injected, because the page that would say it sits behind the account wall.
Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.
Who prescribes
A licensed clinician
The About page names the doctors on the team: John H. Hamilton, MD, as medical director, and Jared Folwell, MD, alongside a nurse practitioner, Angie Tuzson. It does not say which of them reviews a given request, and there is no state-by-state license list. The product pages describe a provider who guides technique and dosing during a consultation and monitors the protocol afterwards. The same About page calls the company LegitScript certified.
The entry point is a free 15-minute telehealth call with a provider rather than an intake questionnaire, and the home page says approval can come within about an hour of it. The site also leans on a text-message channel, inviting a reader to text the team about anything the catalog does not cover. Dose adjustment and follow-up are described as part of the provider relationship, and the membership plans add automated monthly delivery with priority during a shortage.
Are labs required?
Never mentioned
Bloodwork is never mentioned on any reachable page, in any product description or in the terms, so Rehydra+ neither requires labs nor sells them as far as the public site states.
Ready to start with Rehydra+ Wellness?
Lowest listed price: Semaglutide injection, from $149 per 4 wks ($161 a calendar month, our arithmetic). Confirm it on the seller’s own site.
What it claims, and what it cites
The NAD+ page is the one to read carefully, because it makes a therapeutic claim about addiction and then, in the same paragraph, concedes that the human trials behind it have not been published. That is an unusually candid admission sitting directly underneath an unusually strong claim, and nothing else on the page resolves the tension. The customer quotes beside it are first names only.
| On Rehydra+ Wellness’s site | Source it gives |
|---|---|
| On Rehydra+ Wellness’s site“NAD+-replacement treatment may help cure addiction while promoting mitochondrial health and homeostasis, genomic stability, neuroprotection, healthy aging, and lifespan.” | Source it givesNone given |
| On Rehydra+ Wellness’s site“However, clinical trials evaluating these effects in humans treated with NAD+ injection have not yet been published.” | Source it givesThe seller's own caveat, printed in the same paragraph as the claim above |
| On Rehydra+ Wellness’s site“Injectable NAD+ delivers direct, high-bioavailability replenishment that supplements simply cannot match.” | Source it givesNone given |
| On Rehydra+ Wellness’s site“By the four- to eight-week mark, consistent and measurable weight loss is typically well underway.” | Source it givesNone given |
Sold by Rehydra+ Wellness, not listed here
- BPC-157
- On no 503A list (removed from Category 2 in April 2026, never in Category 1). The FDA's compounding advisory committee voted 8–6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- KPV
- On no FDA compounding list. KPV appears in neither the 503A bulk drug substances categories (updated May 14, 2026) nor the 503B categories (updated March 21, 2025). FDA's compounding advisory committee voted 8-6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- MOTS-c
- On no 503A list (not in Categories 1–3 of the May 14, 2026 update). The FDA's compounding advisory committee voted 7–5 (two abstentions) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- Tesamorelin
- Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
- TB-500
- On no FDA compounding list: absent from the 503A categories (updated May 14, 2026) and the 503B categories (updated March 21, 2025). FDA's compounding advisory committee voted 8-6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
- GHK-Cu
- "GHK-Cu (except for injectable routes of administration)" is in 503A Category 1 (list updated May 14, 2026). The injectable route is on no list.
- KPV
- A peptide fragment on no compounding list, so this site lists no seller for it.
- The Glow and Klow blends
- Multi-peptide blends whose named components include research-only compounds; this site lists a compound only where it is sold on its own.
- Lipo-Plus (Bioboost)
- A lipotropic and B-vitamin injection, not a peptide.
- Testosterone therapy
- Hormone therapy outside the peptides this site covers.
How it bills
The semaglutide membership runs $119 a month at tier one against a stated normal price of $199, rising to $169 against $269 and $229 against $319. The tirzepatide tiers are $169 against $344, $289 against $519 and $399 against $719. Each of those discounted rates buys a six-month membership the page labels non-cancelable. The normal price beside each tier matches nothing the shop sells on its own. Without the membership, a one-time vial covers four weeks and is priced by dose, from $149 for semaglutide and $219 for tirzepatide, with a separate 2.5 mg listing at $399 for six weeks. Membership also includes a free ten-week supply of B12 injections. A third-party financing option is offered at the checkout.
Availability: 20 states, per the About page; no list of which states is published
For and against
- For: Milligram range printed for every GLP-1 tier
- For: Full price printed beside each discounted tier
- For: NAD+ sold as a stated 30-day supply
- For: Financing offered at checkout
- Against: Peptide product pages redirect to a login
- Against: GLP-1 memberships are six months, non-cancelable
- Against: No list behind the 20-state claim
- Against: An addiction claim the page itself cannot support
The evidence behind what it sells
- Tirzepatide Headache: What the Labels and Trial Results Recorded
- Does NAD Cause Cancer? What Human and Animal Studies Show
- Sermorelin vs HGH: A Signal to the Pituitary or the Hormone Itself
- Does Tirzepatide Make You Tired? What the Trials and Labels Show
- NAD for Parkinson's: What the Human Trials Have Found So Far
- Does Sermorelin Work? What the Human Studies Measured
Right for
Readers who want a compounded GLP-1 with the milligram range attached to the price, and who are willing to sign up for six months to get the lower rate.
Look elsewhere if
Anyone comparing sermorelin prices, since the product page will not open without an account, and anyone who needs to be able to cancel.
Other sellers for weight
50 Stars Health
Also prescribes Semaglutide, Tirzepatide.
Actin
Also prescribes Semaglutide, Tirzepatide.
AgelessRx
Also prescribes Semaglutide, Tirzepatide.
Rehydra+ Wellness
Frequently asked questions
- Can I see Rehydra+'s sermorelin page without an account?
- No. The sermorelin product page redirects to the account login, and so do the GHK-Cu, BPC-157 and tesamorelin pages. Only the shop grid still shows a price.
- Is the $119 semaglutide rate a monthly price?
- It is billed monthly, but it buys a six-month membership the page marks non-cancelable. Without that commitment, the one-time four-week vial at the starting dose is $149.
- Does Rehydra+ publish an NAD+ dose?
- No. The page prices a stated 30-day supply at $279 and says the provider sets the dosing schedule during the consultation.
See what Rehydra+ Wellness prescribes today
Rehydra+ Wellness sets its own prices, plans and the states it serves. Check them before you start.